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   An experimental model of intracutaneous infection in the guinea pig, which was based 
on the study of MILES et al. (Br. J. Exp. Path. 38: 79-96, 1957) :and MASKELL (J. 
Med. Microbiol. 14: 131-140, 1981), was used to investigate the pathogenicity and the 
effect of chemotherapy with lincomycin, using 36 strains of the genus Bacteroides. The 
pathogenicity was estimated by intracutaneous injection of 0.1-ml quantities of bacterial 
suspension into guinea pigs and the value was expressed as the number of inoculated 
organisms required to induce a skin lesion 10 mm in diameter 24 hours after injection. 
Bacteroides fragilis was, on average, three times as pathogenic as non-B. fragilis strains 
(p<0.1). Two intramuscular injections of lincomycin were more effective than a single 
one against the intracutaneous infection, and the lower was the MIC value, the greater 
was the effect (p<0.001). This experimental animal model was simple and convenient 
for estimating the pathogenicity and efficacy of antimicrobial agents. However, the skin 
lesions were often not clear if the bacteria with low virulence were inoculated and the 
induced infection is not natural. 
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                  INTRODUCTION 
     Many kinds of experimental animal model in bacterial infection have been developed 
for estimating the pathogenicity and the effect of antimicrobial treatment. We attempted 
to evaluate the method of intracutaneous infection in the guinea pig based on the those
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of MILES") and MASKELLI5) using the genus Bacteroides. Bacteroides species are fre-
quently isolated from human clinical specimens and play an important role in anaerobic 
infection. It is well known that Bacteroides fragilis among the species of the genus Bac-
teroides is most frequently recognized as a causative pathogen in intraabdominal, posto-
perative, female genital and respiratory infections, and in bacteremia6). Bacteroides spe-
cies are the major components of the normal flora of the large intestine, and B. fragilis 
is a minor component9"17>, but it is more often isolated from clinical specimens and 
causes infections more frequently than non-B. fragilis strains. As a reason for the higher 
incidence of endogenous infections due to B. fragilis compared with non-B. fragilis 
species, several pathogenic factors have been proposed for B. fragilis3)4)1O>11)12)13)1e)21) 
In the present study, the pathogenicity of B. fragilis was compared with that of non-
B. fragilis species by using intracutaneous infection in the guinea pig as an experimental 
model. The effect of the administration of an antibiotic, lincomycin, on infection with B. 
fragilis was also investigated. This paper describes the results of these studies with some 
discussion.
              MATERIALS AND METHODS 
      Bacteria. Twenty-five strains of B. fragilis and 11 of non-B. fragilis strains were 
used ; 23 were from clinical specimens such as pus, wound swabs, blood and ascitic fluid, 
one was B. fragilis G-2 provided by the Institute for Anaerobic Bacteriology, Gifu Uni-
versity School of Medicine, Gifu, Japan ; and the remaining one was a reference strain, 
B. fragilis NCTC 9343. The non-B. fragilis species used consisted of 10 from clinical sp-
ecimens (8 of B. distasonis and 2 of B. thetaiotaomicron) and one of B. uniformis G-
3 from Gifu University. 
     Animals. Female Hartley strain guinea pigs weighing 450-550g were used in this 
study. 
     Preparation of suspensions for animal inoculation. The bacterial strains were cultured 
on a GAM agar medium (NISSUI, JAPAN) for two days at 37°C in an anaerobe box 
incubator (FORMA, USA) in an atmosphere of 10% carbon dioxide, 7 % hydrogen and 
83% nitrogen maintained at a humidity of 60%. The growth was scraped off with a pla-
tinum spatula and suspended densely in sterile saline (NaC1 0.8% w/v in water) in the 
anaerobe box. The number of bacteria in the suspensions was determined by the dilution 
culture method or with a standard curve prepared by photodensitometry. The original su-
spensions and 10-fold dilutions of both living bacteria and organisms which were killed by 
heating in a water bath at 80°C for 30 min were prepared for animal inoculation. 
     Intracutaneous inoculation in guinea pigs. The intracutaneous inoculation was car-
ried out according to the method of MILES et al. 16) . Guinea pigs were divided into 
groups of three, and the hair of the dorsal skin and flanks was shaved off before the 
injection. The bacterial suspension in 0.1-ml volumes was then randomly injected into 
the skin of each guinea pig with a tuberculin needle from 16 to 20 sites at about 2.5-cm
intervals. 
     Evaluation of intracutaneous pathogenicity. Pathogenicity was evaluated according 
to MASKELL's method") as follows. At 24 hours after the inoculation, a barium sulphate 
paste was applied for about 5 min on the shaved skin area of the guinea pig for complete 
depilation and then the diameter of the skin lesion at each inoculated site was measured 
with slide calipers. The pathogenicity of each Bacteroides species was expressed in terms 
of the number of bacteria in 0.1-m1 capable of producing a lesion 10 mm in mean di-
ameter. This value was termed the ED10, and for living and dead bacteria it was ex-
pressed as ED10 (L) and ED10 (D) respectively ; these values were calculated from a graph 
on which were plotted the nlumber of bacteria in the original suspension and7the 10-fold 
dilutions injected and the diameter of the lesion produced by each strain. Pathogenicity 
was estimated on the assumption that the ED10 (L) value expresses the intracutaneous 
multiplication, persistance and invasiveness of the organisms, while the ED10 (D) value 
indicates the toxicity of the bacterial substances. Moreover, the ED10 (D)/ED10 (L) ratio 
(potency ratio) was thought to represent the intracutaneous multiplication or persistence 
of bacteria in the guinea pig. Thus, a low ED10 value means strong pathogenicity, and 
a potency ratio equal to or less than one (L1) indicates lack of multiplication, while a 
potency ratio greater than one (>1) means high multiplication and persistence of bacteria 
in guinea pig skin. 
     Antibiotic and the method of administration. Lincomycin (Upjohn) was employed 
in the current study. Lincomycin at 200 mg/kg was intramuscularly injected into each 
guinea pig in four groups, A-D, each group containing three guinea pigs. Group A 
was the control to which no antibiotic was given, group B was injected with lincomycin 
one hour before the B. fragilis inoculation, group C was given lincomycin six hours after 
the bacterial inoculation, and group D was treated with the antibiotic both one hour be-
fore and six hours after the inoculation of B. fragilis. 
     Measurement of the antibacterial activity and the tissue levels of lincomycin. The 
minimum inhibitory concentrations (MICs) of lincomycin for B. fragilis were measured by 
an agar dilution technique using GAM agar medium. The strains were grown for 24 
hours in GAM broth (NISSUI) and further diluted in broth to provide 104 colony forming 
units when delivered to the surface of the GAM agar medium with a multipoint i noculator 
(SAKUMA, Japan). Doubling dilutions of lincomycin were prepared in 10 mM phos-
phate buffer (pH 7.0) to final concentrations of 100-0.05 ug/ml in GAM agar plate. 
The plates were inocubated in an anaerobe box incubator at 37°C for 24 hours, and then 
the MIC was defined as the lowest concentration resulting in the total suppression of 
growth. The levels of lincomycin in the blood and in the skin lesions of three guinea 
pigs administered 200 mg/kg intramuscularly were measured by the agar well diffusion 
assay method').
                    RESULTS 
Comparison of the pathogenicity of B. fragilis and non-B. fragilis strains.
     In the preliminary study the diameter of the skin lesion was approximately directly 
proportional to the number of the organisms inoculated (r=0.75). The pathogenicity of 
11 strains of B. fragilis was compared with that of 11 non-B. fragilis strains. The results 
obtained are shown in Table 1, in which the lesions caused by living bacteria are seen 
to be generally larger than those caused by the dead organisms. The mean values of 
ED 10 (L) and ED 10 (D) for B. fragilis were approximately two or three times smaller 
than those for non-B. fragilis strains ; these results may suggest stronger pathogenicity of 
B. fragilis than non-B. fragilis strains, but the differences were not statistically significant 
according to Student's t-test. The potency ratio of B. fragilis was greater than that of 
non-B. fragilis strains (p<0.1), suggesting that B. fragilis strains have a greater ability 
to persist or multiply in the guinea pig skin. 
     Tissue levels of lincomycin. Mean lincomycin levels in the serum and skin lesions 
of three guinea pigs are shown in Table 2. Peak levels of lincomycin in the serum and 
skin lesions reached 54 and 23.7 pg/ml, respectively, and generally exceeded the MICs 
used in the current study except for six resistant strains with MICs of X100 pg/ml. 
     The efficacy of lincomycin in intracutaneous infection in the guinea pig. Twenty-
three strains of B. fragilis isolated from clinical specimens were used. The efficacy of 
lincomycin was expressed in terms of the diameter (mm) of the skin lesion 24 hours 
after the intracutaneous injection of 0.1-ml of a suspension with 109 living bacteria/ml. 
The results obtained are shown in Table 3. The skin lesions in the lincomycin treated 
groups B, C and D were smaller than those in the untreated group A (p<0.01), and
Table 1. Comparison of ED10 (D)*, ED10 (L) and ED10 (D): ED10 (L) 
        (potency ratio) of Bacteroides fragilis and non- B. fragilis strains
                  ED10 (D) ED10 (L) ED10 (D) : ED10 (L)                     (x 10 cells) (x 10 cells) 
B. fragilis (11 strains) 5.06± 3.4+ 2.23 ± 2.4 3.89 ± 3.07 
Non-Bl fraglis (11 strains) 10.3 ± 8.1 6.45 ± 7.5 2.35 ± 1.60 
Statistical analysis NS NS p<0.1
* ED10 values are expressed as the number of organisms in 0 .1-m1 required to 
  induce a mean lesion diamter of 10 mm in guinea pig skin; this value was 
  calculated for living and dead organisms and termed ED10 (L) and ED10 (D) 
  respectively. See Maskell (15) and Miles et al. (16). 
} Mean ± SE
Table 2. Mean serum and skin lesion levels (tpg/ml) of lincomycin after 
        intramuscular injection of 200 mg/kg in three guinea pigs
                                Time after injection (hr) 
   Sample 
                 1/2 1 2 4 6 
   Serum 54 36 22.2 9.1 4.0 
   Skin lesion 13.2 23.7 17.3 7.7 4.1
the effect especially strong in the lesions caused by lincomycin sensitive strains in group 
D (p<0.001). The skin lesions due to highly resistant strains were also diminished 
significantly in groups C and D (p<0.05). There was no significant difference between 
groups B and C or C and D by Student's t-test.
Table 3. Relative efficacy of lincomycin administration (200 mg/kg) in intradermal 
        infection of guinea pig caused by injection of 108 Bacteroides fragilis 
         cells in 0.1-ml
Lincomycin MICs of lincomycin (pg/ml) 
administration >100 1.56 - 6.25 50.39 
                     (6 strains) (12 strains) (5 strains)
   A* 5.92 ± 1.38+ 6.76 ± 1.46 6.58 ± 0.70 
   B 4.48 ± 0.77 3.96 ± 1.OOV 4.46 ± 0.847 
   C 4.03 ± 0.76 1 3.88 ± 0.847 4.06 ± 0.257 
   D 3.85 ± 0.67 ( 4.03 ± 0.877 3.22 ± 0.740, ¶
* A : Control (untreated) . 
  B: Lincomycin was given one hr before bacterial inoculation. 
  C: Lincomycin was given six hrs after bacterial inoculation. 
  D: Lincomycin was given one hr before and six hrs after bacterial inoculation. 
+ Mean diameter of the skin lesion (mm) . 
 Significantly different from A p(0.05, 7p<0.01, Op<0.01 
¶ Significantly different from B p<0.05
                    DISCUSSION 
     The goal of this work was to estimate the pathogenicity of the Bacteroides species 
and to select the strains with strong pathogenicity for applying to further experimentally 
infected animal model, and also to evaluate the superiority or inferiority of the method of 
intracutaneous infection in guinea pig. The Bacteroides species are the major group of 
bacteria composing the resident bacterial flora in the intestinal tract, particularly in the 
large intestine. Non-B. fragilis strains such as B. vulgatus, B. distasonis, B. thetaiotao-
micron are more common than B. fragilis. However, B. fragilis is most frequently isolated 
from human specimens and clinical infections due to this organism are often encountered 
9)19) As for the greater pathogenicity of B. fragilis strains, the capsular polysaccharide 
of B. fragilis has been considered to be a virulence factor by many investigators 10) 11)12)13) 
14)18)2°) On the other hand , it has also been reported that the capsule is not only 
characteristic of B. fragilis, but that it is also present rather commonly in non-B. fragilis 
strains except for B. distasonis18). Superoxide dismutase production2l) and resistance to 
opsonin and to the bactericidal action of serum2)3)4)2°) have been reported as other possible 
pathogenic factors of B. fragilis. The results of the present study showed that B. fragilis 
was about three times, on the average, as pathogenic as the non-B. fragilis strains. 
MASKELL15), who used the same experimental model, reported that B. fragilis is 17 
times as pathogenic as non-B. fragilis strains. As a reason for these differences in 
pathogenicity between B. fragilis and non fragilis strains, it was assumed that B. fragilis
would be more persistent in the guinea pig skin. B. fragilis was consistently recovered 
from skin lesions 24 hours after inoculation of the bacteria into the guinea pig skin, while 
non-B. fragilis strains were not recovered in many cases in the present study. 
     The results of investigation on antibiotic therapy showed that two administrations 
of lincomycin, given intramuscularly one hour before and six hours after intracutaneous 
inoculation of the bacteria, were therapeutically most effective (p<0.001). This finding 
seems to be in agreement with the results reported by EAGLE et al .1)6) in a series of ex-
periments. Even if the intracutaneous level of lincomycin was lower than the in vitro 
MIC required to kill the inoculated bacterial strain, this antibiotic showed a significant 
therapeutic effect. This apparent potentiation of the effect of lincomycin was thought to 
be a protective reaction by the neutrophils, macrophages and complements which were 
produced in vivo in response to inoculation of B. fragilis. In the majority of the inoculated 
foci, there were macroscopically observable abscess formation, and histologically many 
polynucleocytes were seen to have infiltrated to the skin along with some macrophages, 
lymphocytes, eosinophils and so on. These findings were observed uniformly in all groups 
of animals inoculated with living or dead suspensions of B. fragilis and non-B. fragilis 
strains. An advantage of the present experimental model is that the pathogenicity of 
many bacterial strains and the in vivo efficacy of the antibiotics can be tested with a 
small number of guinea pigs. On the other hand, the disadvantages are that the skin 
lesions are often not clear if small numbers of bacteria of low virulence are inoculated, 
physical reactions may possibly occur because of the inoculation of a large number (more 
than 107) of bacteria, and the induced infections are not natural.
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